Group items tagged

Multiple myeloma is a type of cancer that forms a type of white blood cell called a plasma cell. In multiple myeloma, cancerous plasma cells gather around the bone marrow and crowd out healthy cells. Some of the most common symptoms of multiple myeloma are pain in the back or bones, anemia, fatigue, and kidney damage. Multiple myelomas can be identified by a biopsy, which is conducted when tissue samples from the affected area are taken and examined under a microscope. When multiple myelomas are detected on an examination, it is typically very easy to remove them with a scalpel, and in many cases, surgeons will opt to remove only one lobe of tissue at a time. There has the development of various multiple myeloma drugs over the years with key industry players being involved in continuous research and development activities. Selinexor is one of the latest U.S. FDA-approved drug for multiple myeloma and is used to treat people suffering from relapsed or refractory disease. Furthermore, Ixazomib is the first and only oral proteasome inhibitor, indicated for multiple myeloma treatment. Read more @ https://coherentmarketinsights-cmi.blogspot.com/2020/12/multiple-myeloma-drugs-are-getting.html

Bone Marrow Transplantation (or BMT) is the specialized treatment of patients suffering from diseases like multiple sclerosis, Parkinson's disease, and multiple myeloma. Hematologic stem cells are usually taken from bone marrow. They are harvested and divided into two types namely autologous and allogenic. Autologous cells are implanted in the diseased area and they work against the disease while allogeneic cells are taken from the bone marrow and used for transplants. In general, BMT is more successful when compared to other treatment modalities. In Germany, around 13,895 people were diagnosed with leukemia with around 4% of them aged 15 years and below. One common cause of blood transfusions is the occurrence of sickle cell anemia. Sickle cell anemia is a disorder wherein the red blood cells of the body are shaped differently from normal. These blood cells are thick and might contain large amounts of iron. A bone marrow transplant can be given after the occurrence of sickle cell anemia. Read more @ https://coherentmarketinsights-cmi.blogspot.com/2021/08/bone-marrow-transplant-has-become.html